| Product Code: ETC7539508 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Industry Life Cycle |
3.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Porter's Five Forces |
3.5 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Analytical Method, 2021 & 2031F |
3.7 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.8 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in cell and gene therapy research and development in India |
4.2.2 Growing adoption of advanced manufacturing technologies in the healthcare sector |
4.2.3 Rising demand for high-quality and reliable quality control measures in the cell and gene therapy manufacturing process |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and compliance standards for cell and gene therapy manufacturing in India |
4.3.2 Limited availability of skilled professionals with expertise in quality control for cell and gene therapy manufacturing |
5 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Trends |
6 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Types |
6.1 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Equipment & Accessories, 2021- 2031F |
6.1.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Analytical Method |
6.2.1 Overview and Analysis |
6.2.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Sterility Testing, 2021- 2031F |
6.2.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Purity Testing, 2021- 2031F |
6.2.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Potency Testing, 2021- 2031F |
6.2.5 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Identity Testing, 2021- 2031F |
6.2.6 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By Process |
6.3.1 Overview and Analysis |
6.3.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Upstream Processes, 2021- 2031F |
6.3.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Downstream Processes, 2021- 2031F |
6.3.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Process Development, 2021- 2031F |
6.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.4.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenues & Volume, By Contract Manufacturing Organizations, 2021- 2031F |
7 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Import-Export Trade Statistics |
7.1 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Export to Major Countries |
7.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Imports from Major Countries |
8 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Key Performance Indicators |
8.1 Percentage of cell and gene therapy manufacturing facilities in India implementing quality control measures as per regulatory standards |
8.2 Number of partnerships and collaborations between Indian cell and gene therapy manufacturing companies and quality control technology providers |
8.3 Rate of adoption of automation and digitalization in quality control processes in the Indian cell and gene therapy manufacturing sector |
9 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Opportunity Assessment |
9.1 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Analytical Method, 2021 & 2031F |
9.3 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By Process, 2021 & 2031F |
9.4 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market - Competitive Landscape |
10.1 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Revenue Share, By Companies, 2024 |
10.2 India Cell and Gene Therapy Manufacturing Quality Control (QC) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here